Pyxis Oncology, Inc. — Director's Dealing 2023

Sep 8, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pyxis Oncology, Inc. (PYXS)
CIK: 0001782223
Period of Report: 2023-09-07

Reporting Person: Sullivan Lara (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-07	Common Stock	A	469483	$0.00	Acquired	2625182	Direct

Footnotes

F1: Represents restricted stock units that are fully vested.